HealthEquity (HQY) Tops Q3 EPS by 10c, Beats on Revenue; Offers Guidance

HealthEquity (NASDAQ: HQY) reported Q3 EPS of $1.01, $0.10 better than the analyst estimate of $0.91. Revenue for the quarter came in at $322.2 million versus the consensus estimate of $320.92 million.

GUIDANCE:

HealthEquity sees FY2026 EPS of $3.87-$3.95, versus the consensus of $3.89. HealthEquity sees FY2026 revenue of $1.3-1.31 billion, versus the consensus of $1.31 billion.

For earnings history and earnings-related data on HealthEquity (HQY) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
• Stifel Canada Starts BlackBerry (BB) at Buy